I am honored to once again present at the Annual Compliance Week Washington DC Conference. On Monday, May 22, 2017, at 11:30, I will moderate a panel, Prevention and Profits: A Deep Dive Into Managing Incentive Programs.
Incentives are seen as integral to business and are a proven means to motivate employees to reach goals and commercial objectives. But incentives can have unintended and invisible side-effects by leading employees to bend the rules to the needs of forecasts, targets and quotas. In this session we’ll discuss how to index incentives and measures to ethical and commercial success, as well as the process – and role of the compliance officer – in revamping performance management systems, including overcoming opposition, communicating with employees, and maintaining business performance. Joining me will be Matthew D’Ambrosio, SVP, Chief Compliance and Ethics officer at Sunovion Pharmaceuticals Inc. as well as Michael Shaw, VP and compliance office for GlaxoSmithKline. The full event site can be found here.